SRI Meeting: Training and Development in the Reproductive Sciences
SRI Meeting: Training and Development in the Reproductive Sciences
批准号:
10609173
负责人:
Dineo Khabele
金额:
$1.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-02-15 至 2027-12-31
关键词:
AreaAtmosphereAustraliaAwardBasic ScienceBiochemistryBritish ColumbiaCanadaClinicalClinical SciencesCollaborationsCommunicable DiseasesDedicationsDevelopmentDevelopmental BiologyDisciplineDiscipline of obstetricsDoctor of PhilosophyEducational workshopEnsureEnvironmentEpidemiologyEventExposure toFertilizationFosteringFoundationsFundingFuture GenerationsGeneticGoalsGovernmentGrantGynecologic OncologyGynecologyHealth SciencesHealthcareHearingHeightImmunologyIndividualInternationalInvestigationMedicineMentorsMinorityMissionOralPerinatologyPharmacologyPrivatizationProductivityProfessional OrganizationsReportingReproductionReproductive BiologyReproductive EndocrinologyReproductive ImmunologyReproductive MedicineReproductive PhysiologyReproductive SciencesResearchResearch PersonnelScheduleScienceScientistSocietiesStudentsStudy SectionTechniquesTechnologyTrainingTranslational ResearchTravelUnderrepresented MinorityUnited States National Institutes of HealthWomanWomen&aposs HealthWorkcareercareer developmentcostequity, diversity, and inclusionhealth disparitylecturerlecturesmeetingsmembernext generationpostersprogramsreproductiveresearch and developmentstem cell biologysymposium
中文摘要
项目总结
生殖研究学会(SRI)的年度会议汇集了临床和基础研究
来自世界各地的科学家讨论与妇女健康和生殖科学相关的研究。
非常成功的SRI年度会议在过去的几年中平均有1062名调查人员出席
在过去的五年中,他召集了资深和初级调查人员进行报告和讨论
他们的发现在有利于坦率而友好的交流的气氛中进行。这项申请寻求资金
用于支付旅费,以允许7名受训人员和新的调查员出席SRI年度会议。这
该提案还寻求资金,以支持一名驻美国的高级调查员的旅费,他将在
应邀在会上发表杰出总统演讲。会议安排在每年3月举行。
澳大利亚布里斯班(2023年)和加拿大不列颠哥伦比亚省温哥华(2024年)。四天的时间
会议包括两到三次杰出总统演讲,口头和海报演示,12个迷你
专题讨论会、新的调查员全体会议、职业发展和多样性论坛以及网络活动。
第70届SRI年度科学会议将于3月21-25日在澳大利亚布里斯班举行。SRI的意志
继续努力确保新的调查员、任职人数偏低的少数族裔有足够的代表
妇女作为每次年会的与会者、演讲者和会议主席。
英文摘要
PROJECT SUMMARY
The annual Society for Reproductive Investigation (SRI) meeting brings together both clinical and basic
scientists from around the world to discuss research related to women's health and reproductive science.
The highly successful annual SRI meeting has had an average attendance of 1062 investigators over the
last five years and has brought together established senior and junior investigators to report and discuss
their findings in an atmosphere conducive to frank yet amicable exchange. This application seeks funding
to cover travel costs to allow seven trainees and new investigators to attend SRI annual meetings. This
proposal also seeks funding to support the travel costs of a senior US-based investigator who will present
an invited Distinguished Presidential lecture at the meeting. Meetings are scheduled in March of each
year in Brisbane, Australia (2023) and Vancouver, British Columbia, Canada (2024). The four-day
meeting includes two or three Distinguished Presidential Lectures, oral and poster presentations, 12 mini-
symposia, a new investigator plenary, career development and diversity forums, and networking events.
The 70th Annual SRI Scientific Meeting will be held in Brisbane, Australia, March 21-25. The SRI will
continue its efforts to ensure adequate representation of new investigators, underrepresented minorities
and women as attendees, speakers, and session chairs at each annual meeting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer
-
批准号:10362606
-
项目类别:
-
资助金额:$42.4万
-
财政年份:2020
-
负责人:Dineo Khabele
-
依托单位:
Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer
-
批准号:10207160
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2020
-
负责人:Dineo Khabele
-
依托单位:
Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer
-
批准号:10737850
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2020
-
负责人:Dineo Khabele
-
依托单位:
Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer
-
批准号:10117210
-
项目类别:
-
资助金额:$44.69万
-
财政年份:2020
-
负责人:Dineo Khabele
-
依托单位:
Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer
-
批准号:10578788
-
项目类别:
-
资助金额:$44.61万
-
财政年份:2020
-
负责人:Dineo Khabele
-
依托单位:
Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer - Diversity Supplement
-
批准号:10599719
-
项目类别:
-
资助金额:$6.95万
-
财政年份:2020
-
负责人:Dineo Khabele
-
依托单位:
Targeting Cyclin E in Ovarian Cancer with Histone Deacetylase Inhibitors
-
批准号:9298005
-
项目类别:
-
资助金额:$18.2万
-
财政年份:2017
-
负责人:Dineo Khabele
-
依托单位:
Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer
-
批准号:8066414
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2010
-
负责人:Dineo Khabele
-
依托单位:
Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer
-
批准号:8460917
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2010
-
负责人:Dineo Khabele
-
依托单位:
Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer
-
批准号:8260292
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2010
-
负责人:Dineo Khabele
-
依托单位:
Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer
-
批准号:7871853
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2010
-
负责人:Dineo Khabele
-
依托单位:
Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer
-
批准号:8672609
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2010
-
负责人:Dineo Khabele
-
依托单位:
DISSECTING COX-1 RELATED GENE PATHWAYS IN OVARIAN CANCER
-
批准号:7959187
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2009
-
负责人:Dineo Khabele
-
依托单位:
DISSECTING COX-1 RELATED GENE PATHWAYS IN OVARIAN CANCER
-
批准号:7715280
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2008
-
负责人:Dineo Khabele
-
依托单位:
DISSECTING COX-1 RELATED GENE PATHWAYS IN OVARIAN CANCER
-
批准号:7561525
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2007
-
负责人:Dineo Khabele
-
依托单位:
DISSECTING COX-1 RELATED GENE PATHWAYS IN OVARIAN CANCER
-
批准号:7335978
-
项目类别:
-
资助金额:$10.34万
-
财政年份:2006
-
负责人:Dineo Khabele
-
依托单位:
国内基金
海外基金
图们江流域农村生活污水处理中Atmosphere-Exposed Biofilm的净化机理及动力学研究
-
批准号:51269032
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2012
-
负责人:金明姬
-
依托单位: